Dromostanolone propionate(Synonyms: Drostanolone propionate)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Dromostanolone propionate (Synonyms: Drostanolone propionate) 纯度: ≥97.0%

Dromostanolone propionate (Drostanolone propionate) 是一种具有抗乳腺癌活性的化合物。Dromostanolone propionate 能抑制肿瘤对雌二醇 -17ß 的摄取,但对正常乳腺组织的摄取没有明显影响。Dromostanolone propionate 植入颗粒能使动物的体重增加并抑制雌性动物发情。

Dromostanolone propionate(Synonyms: Drostanolone propionate)

Dromostanolone propionate Chemical Structure

CAS No. : 521-12-0

规格 价格 是否有货 数量
50 mg ¥500 In-stock
100 mg ¥850 In-stock
200 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Dromostanolone propionate (Drostanolone propionate) is a compound has antitumor activity against breast carcinoma[1]. Dromostanolone propionate inhibits the uptake of oestradiol-17ß by the tumour but has no apparent effect on the uptake by normal breast tissue [2]. Dromostanolone propionate implant pellet produces weight gains in animals and suppresses estrus in female animals[3].

分子量

360.53

Formula

C23H36O3

CAS 号

521-12-0

中文名称

屈他雄酮丙酸酯

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

参考文献
  • [1]. Takeuchi S, et al. Clinical experience with dromostanolone propionate (NSC-12198) in breast carcinoma. Saishin Igaku. 1967 May;22(5):1049-54.

    [2]. N.Deshpande, et al. Accumulation of tritiated oestradiol by human breast tissue. Steroids, 1967 Sep;10(3), 219–232.

    [3]. Brian H. Vickery . Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals. US3991750A.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Methyl propionate-PEG12

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Methyl propionate-PEG12 

Methyl propionate-PEG12 是一种 PROTAC linker,属于 PEG 类。可用于合成 PROTAC 分子。

Methyl propionate-PEG12

Methyl propionate-PEG12 Chemical Structure

CAS No. : 1239588-11-4

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Methyl propionate-PEG12 is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1].

IC50 & Target

PEGs

 

Alkyl/ether

 

体外研究
(In Vitro)

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

632.74

Formula

C28H56O15

CAS 号

1239588-11-4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Camptothecin-20(S)-O-propionate(Synonyms: Camptothecin-20-O-propionate)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Camptothecin-20(S)-O-propionate (Synonyms: Camptothecin-20-O-propionate) 纯度: 98.43%

Camptothecin-20(S)-O-propionate (CZ48) 是喜树碱 (CPT) 的类似物,是强效的抗肿瘤化合物。Camptothecin-20(S)-O-propionate (CZ48) 是拓扑异构酶 I (topoisomerase-Ι) 的抑制剂。

Camptothecin-20(S)-O-propionate(Synonyms: Camptothecin-20-O-propionate)

Camptothecin-20(S)-O-propionate Chemical Structure

CAS No. : 194414-69-2

规格 价格 是否有货 数量
10 mM * 1 mL in DMSO ¥3850 In-stock
5 mg ¥3500 In-stock
10 mg ¥5800 In-stock
50 mg ¥16500 In-stock
100 mg ¥25500 In-stock
200 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

Camptothecin-20(S)-O-propionate 相关产品

相关化合物库:

  • Clinical Compound Library Plus
  • Bioactive Compound Library Plus
  • Cell Cycle/DNA Damage Compound Library
  • Anti-Cancer Compound Library
  • Clinical Compound Library
  • Anti-Aging Compound Library
  • Anti-Lung Cancer Compound Library

生物活性

Camptothecin-20(S)-O-propionate (CZ48), the C20-propionate ester of CPT, is a highly effective anticancer agent. Camptothecin-20(S)-O-propionate (CZ48) is a topoisomerase-Ι inhibitor[1][2][3].

体内研究
(In Vivo)

Camptothecin-20(S)-O-propionate (CZ48, gavage, 100 to 2000 mg/kg/day) exhibits anti-tumor activity in CLO-breast carcinoma (100 mg/kg) and PC3-prostate carcinoma (1000 mg/kg) models in mice[3].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: A tumor xenograft growing in a nude mouse (size, ∼1 cm3)[3].
Dosage: 100-1000 mg/kg/day.
Administration: Oral gavage, for 2, 4 and 6 days, respectively.
Result: Exhibited anti-tumor effect.

Clinical Trial

分子量

404.42

Formula

C23H20N2O5

CAS 号

194414-69-2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
溶解性数据
In Vitro: 

DMSO : 9.09 mg/mL (22.48 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.4727 mL 12.3634 mL 24.7268 mL
5 mM 0.4945 mL 2.4727 mL 4.9454 mL
10 mM 0.2473 mL 1.2363 mL 2.4727 mL

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

参考文献
  • [1]. Zhisong Cao, et al. Crystalline camptothecin-20(S)-O-propionate hydrate: a novel anticancer agent with strong activity against 19 human tumor xenografts. Cancer Res. 2009 Jun 1;69(11):4742-9.

    [2]. Zhisong Cao, et al. Crystalline camptothecin-20(S)-O-propionate hydrate: a novel anticancer agent with strong activity against 19 human tumor xenografts. Cancer Res. 2009 Jun 1;69(11):4742-9.

    [3]. Xing Liu, et al. Correlation between the sensitivity of tumors to treatment with CZ48 and local concentrations of the active metabolite CPT within the tumors. Biomed Rep. 2013 Mar;1(2):202-206.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

N-Succinimidyl 3-(Bromoacetamido)propionate(Synonyms: 3-(2-Bromoacetamido)propanoic acid NHS ester)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

N-Succinimidyl 3-(Bromoacetamido)propionate (Synonyms: 3-(2-Bromoacetamido)propanoic acid NHS ester)

N-Succinimidyl 3-(Bromoacetamido)propionate 是一种 PROTAC linker,属于 PEG 类。可用于合成PROTAC分子。N-Succinimidyl 3-(Bromoacetamido)propionate 也是一种可降解 (cleavable) 的 ADC linker,可用于合成抗体偶联药物 (ADC)。

N-Succinimidyl 3-(Bromoacetamido)propionate(Synonyms: 3-(2-Bromoacetamido)propanoic acid NHS ester)

N-Succinimidyl 3-(Bromoacetamido)propionate Chemical Structure

CAS No. : 57159-62-3

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

N-Succinimidyl 3-(Bromoacetamido)propionate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. N-Succinimidyl 3-(Bromoacetamido)propionate is also a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[2].

IC50 & Target

PEGs

 

Alkyl/ether

 

Cleavable

 

体外研究
(In Vitro)

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[2].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

307.10

Formula

C9H11BrN2O5

CAS 号

57159-62-3

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.

    [2]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

N-Succinimidyl 3-(Bromoacetamido)propionate(Synonyms: 3-(2-Bromoacetamido)propanoic acid NHS ester)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

N-Succinimidyl 3-(Bromoacetamido)propionate (Synonyms: 3-(2-Bromoacetamido)propanoic acid NHS ester)

N-Succinimidyl 3-(Bromoacetamido)propionate 是一种 PROTAC linker,属于 PEG 类。可用于合成PROTAC分子。N-Succinimidyl 3-(Bromoacetamido)propionate 也是一种可降解 (cleavable) 的 ADC linker,可用于合成抗体偶联药物 (ADC)。

N-Succinimidyl 3-(Bromoacetamido)propionate(Synonyms: 3-(2-Bromoacetamido)propanoic acid NHS ester)

N-Succinimidyl 3-(Bromoacetamido)propionate Chemical Structure

CAS No. : 57159-62-3

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

N-Succinimidyl 3-(Bromoacetamido)propionate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. N-Succinimidyl 3-(Bromoacetamido)propionate is also a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[2].

IC50 & Target

PEGs

 

Alkyl/ether

 

Cleavable

 

体外研究
(In Vitro)

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[2].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

307.10

Formula

C9H11BrN2O5

CAS 号

57159-62-3

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.

    [2]. Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务